NCT06614608 - The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions

Osteoarthritis, KneePain

Interventions

DRUG

5% ASKC200

5% ASKC200 is a multi-component formulation in which the active ingredient for the intended therapeutic effect is capsaicin at a level of 5% for this study.

DRUG

1% ASKC200

1% ASKC200 is a multi-component formulation in which the active ingredient for the intended therapeutic effect is capsaicin at a level of1% for this study.

Trial Locations (1)

100730

Beijing Hospital, Beijing